The Challenger share price fell 34% in 2018 – can it bounce back in 2019?

Despite a poor 2018, I believe that Challenger Ltd (ASX: CGF) can have strong share price appreciation in 2019 and beyond.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

Amongst the wider market sell-off, the Challenger Ltd (ASX: CGF) share price fell 34% in 2018.

Challenger is an investment management firm that can be split into two main businesses: Life and Funds Management. Challenger's Life division offers annuities which cater to people in retirement. The company is Australia's leading provider of annuities, servicing more than 60,000 people who want or need reliable income streams.

Despite a poor 2018, I believe that Challenger can have strong share price appreciation in 2019 and beyond.

Challenger is the top dog in the Australian annuities market. The company's products dominate the industry with approximately 90% market share. Even if Challenger can only maintain its current market share, the company should grow earnings over time. This is because of two tailwinds: Australia's changing demographics and superannuation.

An investment theme that is impacting industries ranging from healthcare to funeral services is Australia's aging population. Baby boomers have been turning 65 since 2011 and will continue to do so until 2029. This will result in the number of retirees over 65 growing 40% in the next decade. As more people enter retirement they will need to live off income streams such as annuities.

The government has identified this and as a result they have made it a requirement that all Super funds offer guaranteed income products.

The 9.5% Superannuation Guarantee means that the pool of funds in Super accounts keeps growing. The mandatory rate of contribution is also increasing to 12% in FY26. This will further accelerate the volume of funds that can be transitioned into annuities.

Another positive for Challenger's stock is its valuation. The company currently trades at 18x earnings. This is slightly above the market average of 16/17x earnings. Considering the Superannuation and demographic tailwinds impacting on the business, I believe that this is very reasonable.

Foolish takeaway

Not many businesses boast the tailwinds and government support that Challenger currently enjoys. Policies can change over time, however as healthcare improves and the baby boomer generation matures we will continue to see a growing population of retirees. Challenger is the leader in annuities and stands to benefit most from this trend. The company's share price should do well over the long term.

Motley Fool contributor Lloyd Prout owns shares of Challenger Limited and expresses his own opinions. The Motley Fool Australia owns shares of and has recommended Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

An old-fashioned news boy stands on a stool and yells through a microphone in an open field.
Share Market News

Why is everyone talking about Core Lithium, Ampol and Santos shares on Thursday?

Ampol, Core Lithium and Santos shares are making waves on Thursday. But why?

Read more »

A boy in a green shirt holds up his hands in front of a screen full of question marks.
Share Market News

Are Xero shares a buy after rebounding 17% from three-year low

The tech stock bottomed at a multi-year low of $70.42 earlier this month.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Broker reiterates buy ratings on 2 ASX shares

These ASX shares remain worth watching.

Read more »

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

After more than quadrupling investors' money in a year, are PLS shares still a buy?

A leading analyst delivers his outlook for the soaring PLS share price.

Read more »

A young man wearing a bright yellow jumper and glasses purses his lips together and moves them to the side of his face as he wonders about something.
Broker Notes

Buy, hold, or sell? Life360, Iress, Lynas Rare Earths shares

Experts reveal their views.

Read more »

Worried woman calculating domestic bills.
Broker Notes

Why did this broker just lower its outlook on this ASX 200 stock?

Despite a lowered outlook, attractive upside remains.

Read more »

Three climbers scramble up a rocky peak overlooking a vast snow covered mountain range with an icy blue sky beyond them.
52-Week Highs

What are experts saying about these red hot ASX 200 shares?

These stocks are soaring right now.

Read more »

Shocked office worker staring at computer screen with colleagues working in the background.
Broker Notes

Buy, hold, sell: Cleanaway, Hub24, and MAAS shares

Morgans has given its verdict on these shares. Is it bullish or bearish? Let's find out.

Read more »